WADA Status The World Anti-Doping Agency (WADA) added BPC-157 to its Prohibited List under section S0 (Non-Approved Substances)
Retatrutide adds a third receptor - glucagon - making it the first triple agonist in clinical development
Places Order for 20,000 BPC-157 Transdermal Patches May 26, 2026 The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA) May 21, 2026 The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch May 19, 2026 The Precision Peptide Companys Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey May 14, 2026 The Precision Peptide Company Inc
Vitamin C Petrolatum, ceresin, paraffinum liquidum, ethylhexyl methoxycinnamate, octyldodecanol, octocrylene, neopentyl glycol diethylhexanoate, c12-15 alkyl benzoate, ethylhexyl salicylate, butyl methoxydibenzoylmethane, ascorbyl palmitate, macadamia ternifolia seed oil, candelilla cera, bis-diglyceryl polyacyladipate-2, ppg-3 benzyl ether myristate, microcrystalline wax, polyethylene, c20-40 alcohols, vegetable oil, phenoxyethanol, tocopheryl acetate, parfum, linalool, benzyl benzoate, limonene
